[
  {
    "id": "agent-patient-profile-001",
    "type": "agent",
    "x": 400,
    "y": 200,
    "width": 520,
    "height": 800,
    "content": "## Patient Profile: Sarah Miller\n\n### Demographics\n- **Age:** 43 years\n- **Sex:** Female\n- **Occupation:** Senior Accountant\n\n### Primary Diagnosis\n- Severe polyarticular rheumatoid arthritis (RA)\n- Diagnosed in early thirties\n\n### Current Medications\n- Tofacitinib (Xeljanz) 5mg BID\n- Desoximetasone cream 0.25% daily\n- Ibuprofen 400mg PRN\n\n### Key Concerns\n- Morning stiffness (1-2 hours)\n- Chronic fatigue\n- Intermittent skin lesions",
    "color": "#ffffff",
    "rotation": 0,
    "agentData": {
      "title": "Patient Profile",
      "markdown": "## Patient Profile: Sarah Miller\n\n### Demographics\n- **Age:** 43 years\n- **Sex:** Female\n- **Occupation:** Senior Accountant\n\n### Primary Diagnosis\n- Severe polyarticular rheumatoid arthritis (RA)\n- Diagnosed in early thirties\n\n### Current Medications\n- Tofacitinib (Xeljanz) 5mg BID\n- Desoximetasone cream 0.25% daily\n- Ibuprofen 400mg PRN\n\n### Key Concerns\n- Morning stiffness (1-2 hours)\n- Chronic fatigue\n- Intermittent skin lesions"
    },
    "createdAt": "2025-10-15T08:00:00.000Z",
    "updatedAt": "2025-10-15T08:00:00.000Z"
  },
  {
    "id": "agent-risk-assessment-001",
    "type": "agent",
    "x": 950,
    "y": 200,
    "width": 520,
    "height": 900,
    "content": "# Risk Assessment\n\n## Risk Level: HIGH\n\n### Primary Concern\nDrug-Induced Liver Injury (DILI)\n\n### Key Risk Factors\n1. **Methotrexate Exposure**\n   - 15mg weekly reintroduction\n   - Prior GI intolerance\n   - Inconsistent folic acid intake\n\n2. **Monitoring Gap**\n   - No LFT monitoring after Feb 2025\n   - Critical gap during high-risk period\n\n3. **Clinical Symptoms**\n   - Worsening chronic fatigue\n   - Timeline aligns with drug exposure\n\n4. **Metabolic Factors**\n   - Class I obesity (BMI 27-29.8)\n   - Type 2 Diabetes Mellitus\n   - Hypertension\n   - Hyperlipidemia\n\n### Probability: 80%\n\n### Recommended Actions\n- Urgent LFT panel\n- Hepatology referral\n- Medication review",
    "color": "#ffffff",
    "rotation": 0,
    "agentData": {
      "title": "Risk Assessment",
      "markdown": "# Risk Assessment\n\n## Risk Level: HIGH\n\n### Primary Concern\nDrug-Induced Liver Injury (DILI)\n\n### Key Risk Factors\n1. **Methotrexate Exposure**\n   - 15mg weekly reintroduction\n   - Prior GI intolerance\n   - Inconsistent folic acid intake\n\n2. **Monitoring Gap**\n   - No LFT monitoring after Feb 2025\n   - Critical gap during high-risk period\n\n3. **Clinical Symptoms**\n   - Worsening chronic fatigue\n   - Timeline aligns with drug exposure\n\n4. **Metabolic Factors**\n   - Class I obesity (BMI 27-29.8)\n   - Type 2 Diabetes Mellitus\n   - Hypertension\n   - Hyperlipidemia\n\n### Probability: 80%\n\n### Recommended Actions\n- Urgent LFT panel\n- Hepatology referral\n- Medication review"
    },
    "createdAt": "2025-10-15T08:05:00.000Z",
    "updatedAt": "2025-10-15T08:05:00.000Z"
  },
  {
    "id": "todo-clinical-actions-001",
    "type": "todo",
    "x": 1500,
    "y": 200,
    "width": 420,
    "height": 450,
    "content": "Clinical Action Items",
    "color": "#ffffff",
    "rotation": 0,
    "todoData": {
      "title": "Clinical Action Items",
      "description": "Urgent actions required for patient Sarah Miller",
      "todos": [
        {
          "text": "Order comprehensive LFT panel (ALT, AST, ALP, GGT, Bilirubin)",
          "status": "todo"
        },
        {
          "text": "Check Hepatitis A, B, C serologies",
          "status": "todo"
        },
        {
          "text": "Order autoimmune markers (ANA, ASMA, LKM-1)",
          "status": "todo"
        },
        {
          "text": "Review medication adherence (MTX, Folic Acid)",
          "status": "in_progress"
        },
        {
          "text": "Refer to Hepatology for evaluation",
          "status": "todo"
        },
        {
          "text": "Schedule follow-up in 2 weeks",
          "status": "done"
        }
      ]
    },
    "createdAt": "2025-10-15T08:10:00.000Z",
    "updatedAt": "2025-10-15T08:10:00.000Z"
  },
  {
    "id": "lab-crp-001",
    "type": "lab-result",
    "x": 400,
    "y": 1100,
    "width": 400,
    "height": 280,
    "content": "C-Reactive Protein",
    "color": "#ffffff",
    "rotation": 0,
    "labResultData": {
      "parameter": "C-Reactive Protein (CRP)",
      "value": "28",
      "unit": "mg/L",
      "status": "warning",
      "range": {
        "min": 0,
        "max": 10,
        "warningMin": 3,
        "warningMax": 10,
        "criticalMin": 0,
        "criticalMax": 3
      },
      "trend": "up"
    },
    "createdAt": "2025-10-15T08:15:00.000Z",
    "updatedAt": "2025-10-15T08:15:00.000Z"
  },
  {
    "id": "lab-esr-001",
    "type": "lab-result",
    "x": 850,
    "y": 1100,
    "width": 400,
    "height": 280,
    "content": "Erythrocyte Sedimentation Rate",
    "color": "#ffffff",
    "rotation": 0,
    "labResultData": {
      "parameter": "ESR",
      "value": "38",
      "unit": "mm/hr",
      "status": "warning",
      "range": {
        "min": 0,
        "max": 20,
        "warningMin": 15,
        "warningMax": 30,
        "criticalMin": 0,
        "criticalMax": 15
      },
      "trend": "stable"
    },
    "createdAt": "2025-10-15T08:20:00.000Z",
    "updatedAt": "2025-10-15T08:20:00.000Z"
  },
  {
    "id": "lab-glucose-001",
    "type": "lab-result",
    "x": 1300,
    "y": 1100,
    "width": 400,
    "height": 280,
    "content": "Fasting Glucose",
    "color": "#ffffff",
    "rotation": 0,
    "labResultData": {
      "parameter": "Fasting Glucose",
      "value": "98",
      "unit": "mg/dL",
      "status": "optimal",
      "range": {
        "min": 70,
        "max": 100,
        "warningMin": 100,
        "warningMax": 125,
        "criticalMin": 70,
        "criticalMax": 100
      },
      "trend": "stable"
    },
    "createdAt": "2025-10-15T08:25:00.000Z",
    "updatedAt": "2025-10-15T08:25:00.000Z"
  },
  {
    "id": "agent-treatment-plan-001",
    "type": "agent",
    "x": 400,
    "y": 1450,
    "width": 520,
    "height": 700,
    "content": "# Treatment Plan\n\n## Current Regimen\n\n### Disease-Modifying Therapy\n- **Tofacitinib (Xeljanz)** 5mg BID\n  - Started: August 2023\n  - Response: Good control of joint symptoms\n  - Continue current dose\n\n### Supportive Care\n- **Desoximetasone cream** 0.25% daily\n  - For skin lesions\n  - PRN application\n\n- **Ibuprofen** 400mg PRN\n  - For breakthrough pain\n  - Max 3 doses/day\n\n## Monitoring Schedule\n\n### Monthly\n- Clinical assessment\n- Joint examination\n- Symptom review\n\n### Quarterly\n- CBC with differential\n- Comprehensive metabolic panel\n- Lipid panel\n\n### Biannually\n- Rheumatoid factor\n- Anti-CCP antibodies\n- Imaging (hands/feet)",
    "color": "#ffffff",
    "rotation": 0,
    "agentData": {
      "title": "Treatment Plan",
      "markdown": "# Treatment Plan\n\n## Current Regimen\n\n### Disease-Modifying Therapy\n- **Tofacitinib (Xeljanz)** 5mg BID\n  - Started: August 2023\n  - Response: Good control of joint symptoms\n  - Continue current dose\n\n### Supportive Care\n- **Desoximetasone cream** 0.25% daily\n  - For skin lesions\n  - PRN application\n\n- **Ibuprofen** 400mg PRN\n  - For breakthrough pain\n  - Max 3 doses/day\n\n## Monitoring Schedule\n\n### Monthly\n- Clinical assessment\n- Joint examination\n- Symptom review\n\n### Quarterly\n- CBC with differential\n- Comprehensive metabolic panel\n- Lipid panel\n\n### Biannually\n- Rheumatoid factor\n- Anti-CCP antibodies\n- Imaging (hands/feet)"
    },
    "createdAt": "2025-10-15T08:30:00.000Z",
    "updatedAt": "2025-10-15T08:30:00.000Z"
  },
  {
    "id": "todo-patient-education-001",
    "type": "todo",
    "x": 950,
    "y": 1450,
    "width": 420,
    "height": 400,
    "content": "Patient Education Topics",
    "color": "#ffffff",
    "rotation": 0,
    "todoData": {
      "title": "Patient Education Topics",
      "description": "Key topics to discuss with patient",
      "todos": [
        {
          "text": "Medication adherence importance",
          "status": "done"
        },
        {
          "text": "Signs of liver dysfunction to watch for",
          "status": "done"
        },
        {
          "text": "Joint protection strategies",
          "status": "in_progress"
        },
        {
          "text": "Dietary modifications for RA",
          "status": "todo"
        },
        {
          "text": "Exercise recommendations",
          "status": "todo"
        }
      ]
    },
    "createdAt": "2025-10-15T08:35:00.000Z",
    "updatedAt": "2025-10-15T08:35:00.000Z"
  }
]